A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia
Hervé Dombret(University of London Institute in Paris), Laurent Degos(Inserm), Antoine Yver(Daiichi Sankyo (United States)), Pierre Fenaux(Saint Louis University Hospital), Réda Bouabdallah(Institut Paoli-Calmettes), Augustin Ferrant(Cliniques Universitaires Saint-Luc), Claude Chastang(European Union), Dominique Bordessoule(Centre Hospitalier Universitaire de Limoges), Franco Mandelli(San Antonio College), G Auzanneau(HIA du Val-de-Grâce à Paris), Josy Reiffers(Hôpital Cardiologique du Haut-Lévêque), Hervé Tilly(Centre Virchow-Villermé)
Cited by 313
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k